Bellevue Group AG - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 249 filers reported holding BLUEBIRD BIO INC in Q3 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2020$910,000
-43.3%
19,800
+8.2%
0.02%
-28.0%
Q4 2019$1,606,000
-30.6%
18,300
+0.5%
0.02%
-37.5%
Q2 2019$2,315,000
-36.3%
18,200
-21.2%
0.04%
-80.0%
Q1 2019$3,634,000
+183.9%
23,100
+79.1%
0.20%
+138.1%
Q4 2018$1,280,000
-23.1%
12,900
+13.2%
0.08%
-20.8%
Q3 2018$1,664,000
-17.8%
11,400
-11.6%
0.11%
-38.7%
Q2 2018$2,025,000
-10.8%
12,900
-3.0%
0.17%
-23.1%
Q1 2018$2,271,000
-33.2%
13,300
-30.4%
0.22%
-36.6%
Q4 2017$3,402,000
-1.3%
19,100
-23.9%
0.36%
-1.7%
Q3 2017$3,447,000
+48.4%
25,100
+13.6%
0.36%
+31.3%
Q2 2017$2,322,000
-11.9%
22,100
-23.8%
0.28%
-21.7%
Q1 2017$2,636,000
+47.3%
29,0000.0%0.35%
-4.1%
Q4 2016$1,789,000
-9.0%
29,0000.0%0.37%
+3.1%
Q3 2016$1,966,000
+56.7%
29,0000.0%0.36%
+50.4%
Q2 2016$1,255,000
+1.8%
29,0000.0%0.24%
+5.4%
Q1 2016$1,233,00029,0000.22%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2017
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders